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Several reports have suggested that early neonatal immune activation adversely influences the hypothalam-
ic–pituitary–adrenal (HPA) axis development in humans and animal models. In addition, there have been
several studies indicating that early intervention with fluoxetine (FLX) can alter HPA axis development
and function, and prevent occurrence of behavioral abnormalities induced by common early-life insults.
The present study aims to investigate the effects of early intervention with FLX following early neonatal
immune activation on depression-like behaviors and body weight in mice. Neonatal mice in their postnatal
days (PNDs) 3 and 5 received either lipopolysaccharide (LPS; 50 μg/kg, s.c.) or saline treatment, then male and
female mice of both neonatal intervention groups received oral administration of FLX (5 and 10 mg/kg/day) or
water via regular drinking bottles during the periadolescent period (PNDs 35–65). The results showed that neo-
natal LPS exposure elevated depression-like behaviors accompanied by increasing corticosterone levels in adult-
hood and decreasing body weight during neonatal and adolescent periods. Furthermore, the periadolescent FLX
treatment inhibited the depression-like behaviors induced by neonatal infection in both sexes. This study
obtained some experimental evidence indicating the potential adverse impacts of the FLX on normal behavioral
development inmale control animals. In conclusion, ourfindings suggest that an early pharmacological interven-
tion with FLX may prevent emergence of depression-like behaviors induced by neonatal immune challenge
without any detrimental effect on health in a sex- and dose-dependent manner in mice.
© 2012 Elsevier Inc. All rights reserved.
1. Introduction
There is a great deal of evidence from human and animal studies
indicating that adverse events in neonatal period can negatively affect
the trajectory of normal brain development and function of physiologi-
cal and behavioral systems across the life span (Korosi et al., 2011; Lee
and Dammann, 2011; Pesonen and Räikkönen, 2011; Skripuletz et al.,
2010; Walker et al., 2011; Zakharova, 2009). Several experimental
models have proven a significant link between neonatal exposure to
inflammatory agents like lipopolysaccharide (LPS) and increased likeli-
hood of neuropsychiatric disorders in later life. In this context, multi-
laboratory studies have shown that LPS-induced neonatal immune
activation alters hypothalamic–pituitary–adrenal (HPA) axis activity
(Nilsson et al., 2002; Shanks et al., 1995, 2000) resulting in modifica-
tions of physiological (Iwasa et al., 2010), immunological (Boissé et al.,
2004), behavioral (Shanks et al., 1995), and neuroendocrine (Iwasa et
al., 2009) systems in adulthood.
Previous studies have indicated that LPS exposure on postnatal
days (PNDs) 3 and 5 facilitates anxiety-like behaviors in adult rats
(Sominsky et al., 2011; Walker et al., 2004, 2009). However, little
attention has so far been devoted to the evaluation of early postnatal
inflammation impacts on depression-like behaviors in animal models.
In this regard, we and others have shown that there might be an
association between anxiety and depression-like behaviors (Beuke
et al., 2003; Enayati et al., 2012) in which genes likely have a crucial
role as well as the etiology of these two behaviors (Field et al.,
2010; Kendler et al., 2007; Williamson et al., 2005). Although,
Progress in Neuro-Psychopharmacology & Biological Psychiatry 43 (2013) 55–65
Abbreviations: LPS, lipopolysaccharide; HPA, hypothalamic–pituitary–adrenal;
PND, postnatal day; FLX, fluoxetine; SSRI, selective serotonin reuptake inhibitor; COR,
corticosterone; FST, forced swimming test; TST, tail suspension test; ANOVA, analysis
of variance; NPY, neuropeptide Y; IL, interleukin; TNF-α, tumor necrosis factor-alpha;
BDNF, brain derived neurotrophic factor.
⁎ Corresponding author at: Laboratory of Physiology, Drug Applied Research Center,
Tabriz University of Medical Sciences, P.O. Box 51656-65811, Tabriz, Iran. Tel./fax: +98
919 4099673.
E-mail address: aa.salari@yahoo.com (A.-A. Salari).
0278-5846/$ – see front matter © 2012 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.pnpbp.2012.12.003
Contents lists available at SciVerse ScienceDirect
Progress in Neuro-Psychopharmacology & Biological
Psychiatry
j ourna l homepage: www.e lsev ie r .com/ locate /pnp
